← Back to Search

Audiology Services via Telehealth for Hearing Loss in Aging

N/A
Waitlist Available
Led By Frank R Lin, MD, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must have been eligible for and participated in the hearing intervention arm of the ACHIEVE trial
Age 70-84 years
Must not have
Conductive hearing impairment with air-bone gap >15 dB in two or more contiguous frequencies in both ears
Unwillingness to wear hearing aids on a daily basis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether a telehealth hearing healthcare model is better than the conventional clinic-based model in improving hearing aid use and communication outcomes in older adults.

Who is the study for?
This trial is for older adults aged 70-84 with adult-onset hearing loss who previously participated in the ACHIEVE trial. They must have a mild to moderate hearing impairment and be open to using telehealth or clinic-based hearing care. Exclusions include severe vision impairment, recent use of hearing aids, unwillingness to wear them daily, certain ear conditions, and significant disability in daily activities.
What is being tested?
The study compares two ways of delivering hearing healthcare: traditional in-clinic visits versus telehealth services. It aims to see if telehealth can improve how often older adults use their hearing aids and other communication outcomes compared to standard clinic visits.
What are the potential side effects?
Since this trial involves service delivery methods rather than medications, there are no direct side effects like those associated with drugs. However, participants may experience differences in satisfaction or effectiveness between the two models.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was part of the hearing intervention in the ACHIEVE trial.
Select...
I am between 70 and 84 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have hearing loss where sounds don't reach my inner ear well in both ears.
Select...
I am not willing to wear hearing aids every day.
Select...
I need help with two or more daily activities like eating or dressing.
Select...
I cannot use hearing aids due to a medical issue like draining ear.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Average daily hours of hearing aid use
Secondary study objectives
Ability to hear for primary communication goal as assessed by a single item from the Client-Oriented Scale of Improvement (COSI) goals achievement questionnaire
Hearing-specific quality of life as assessed by the Hearing Handicap Inventory for the Elderly - Screening Version (HHIE-S) questionnaire
Treatment satisfaction as assessed by a single item from the International Outcome Inventory - Comprehensive Hearing Intervention (IOI-CHI) scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Telehealth hearing healthcare groupExperimental Treatment1 Intervention
The telehealth hearing healthcare group will have clinic-based visits every 6 months for the duration of the 2-year study. This group will receive telehealth audiological rehabilitative service delivery and be able to utilize telehealth options, in addition to conventional options, to address any unanticipated needs that arise during both years of the study.
Group II: Conventional hearing healthcare groupExperimental Treatment2 Interventions
The conventional hearing healthcare group will have clinic-based visits every 6 months for the duration of the 2-year study. During Year 1, this group will receive clinic-based audiological rehabilitative service delivery and be able to use conventional options to address any unanticipated needs that arise, and then during Year 2, this group will also receive telehealth audiological rehabilitative service delivery and be able to utilize telehealth options, in addition to conventional options, to address any unanticipated needs that arise.

Find a Location

Who is running the clinical trial?

Wake Forest UniversityOTHER
192 Previous Clinical Trials
165,897 Total Patients Enrolled
2 Trials studying Hearing Loss
30,629 Patients Enrolled for Hearing Loss
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
353 Previous Clinical Trials
181,138 Total Patients Enrolled
60 Trials studying Hearing Loss
21,151 Patients Enrolled for Hearing Loss
Johns Hopkins UniversityLead Sponsor
2,326 Previous Clinical Trials
14,874,390 Total Patients Enrolled
12 Trials studying Hearing Loss
4,349 Patients Enrolled for Hearing Loss

Media Library

Clinic-based audiological rehabilitative service delivery Clinical Trial Eligibility Overview. Trial Name: NCT05070429 — N/A
Hearing Loss Research Study Groups: Conventional hearing healthcare group, Telehealth hearing healthcare group
Hearing Loss Clinical Trial 2023: Clinic-based audiological rehabilitative service delivery Highlights & Side Effects. Trial Name: NCT05070429 — N/A
Clinic-based audiological rehabilitative service delivery 2023 Treatment Timeline for Medical Study. Trial Name: NCT05070429 — N/A
Hearing Loss Patient Testimony for trial: Trial Name: NCT05070429 — N/A
~85 spots leftby Nov 2025